Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure
- 27 November 2024
- journal article
- Published by Elsevier in JACC: Heart Failure
- Vol. 13 (3) , 414-429
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Similarities and Distinctions Between Acetazolamide and Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Acute Heart Failure: Key Insights Into ADVOR and EMPULSEEuropean Journal of Heart Failure, 2023
- Acute Heart Failure is a Remitting–Relapsing Disorder and not a Step Towards Advanced Heart Failure: Implications for Decongestion TherapyEuropean Journal of Heart Failure, 2023
- Impact of Mitral Regurgitation in Patients with Acute Heart Failure: Insights from the RELAX-AHF-2 TrialEuropean Journal of Heart Failure, 2023
- Worsening renal function in acute heart failure in the context of diuretic responseEuropean Journal of Heart Failure, 2021
- Decongestion discriminates risk for one‐year mortality in patients with improving renal function in acute heart failureEuropean Journal of Heart Failure, 2021
- Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX‐AHF ‐2 studyEuropean Journal of Heart Failure, 2020
- Relationship Between Left Ventricular Ejection Fraction and Cardiovascular Outcomes Following Hospitalization for Heart Failure: Insights from the RELAX-AHF-2 TrialEuropean Journal of Heart Failure, 2020
- Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2020
- B-Type Natriuretic Peptide Trend Predicts Clinical Significance of Worsening Renal Function in Acute Heart FailureEuropean Journal of Heart Failure, 2019
- Diuretic Response in Patients with Acute Decompensated Heart Failure: Characteristics and Clinical Outcome—an Analysis from RELAX-AHFEuropean Journal of Heart Failure, 2014